FILE PHOTO: An Aspen Pharmacare logo is seen at outside company offices in Woodmead, Johannesburg, South Africa, September 13, 2018. REUTERS/Siphiwe Sibeko
August 14, 2019
(Reuters) – British authorities said on Wednesday South Africa’s Aspen Pharmacare Holdings Ltd <APNJ.J> has agreed to pay the National Health Service (NHS) 8 million pounds ($9.65 million) to resolve competition concerns related to a company’s treatment.
The Competition and Markets Authority said the settlement follows an investigation into arrangements Aspen made with rival pharmaceutical firms in 2016 to keep them out of the market, boosting its own Addison’s disease treatment, Fludrocortisone, which the NHS pays for.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta)